Blood Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Therapy
Single-dose pegfilgrastim induces stem cell mobilization in malignant lymphoma or multiple myeloma
October 5th, 2006
Single-dose pegfilgrastim after chemotherapy induces stem cell mobilization in malignant lymphoma or multiple myeloma patients. According to a recently published study from Germany, "A single injection of pegfilgrastim has been shown to be equivalent to daily filgrastim in enhancing neutrophil recovery after chemotherapy, whereas the experiences with pegfilgrastim in mobilization of peripheral blood progenitor cells (PBPCs) are limited. "Forty unselected patients with lymphoma or multiple myeloma were treated with different chemotherapy regimens followed by 6 mg of pegfilgrastim for mobilization of autologous PBPCs. Patients with an inadequate...
Source: Blood Weekly (2006-10-05)
|
